Cardiol Therapeutics Inc.

C$1.41As of Sun 8 Nov 2026, 12:00 UTC
TSX:CRDLHealthcare
Country Canada
PE (Fwd) •••
TSR 8Y CAGR (13.61%)
Div yield —
ROE (190.18%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.65
PE TTM —
TSR TTM (8.44%)
Mkt cap C$164.7M
ROIC (124.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.74
23.15%
(39.51%)
Hold 11|11|8|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
17.34%
10.14%
17.93%
18.26%
Revenue$M
12.97
13.07
13.51
14.15
15.33%
10.24%
8.41%
13.85%
Peers (US$116.6M)
Cap (US$)
PE
141.7M
20.72x
124.8M
1.968x
Capital
TTM
5Y
10Y
Leveragex
0.939
0.426
0.408
EBIT/Intx
0.420
0.350
0.352
Own earn%
4.73
108.24
58.84
Sh yield%
22.23
16.29
18.40
Owners
Insiders/Inst%
5.06
59.29
Short interest%
5.39
SBC / revenue%
1.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
3–7
$1 testx
0.0
Incr. ROIC%
2